Optimal Timing of Serial
Disease activity
Follow-up
Left ventricular ejection fraction
Protocol
Resistant
Responder
SUVmax
Journal
International heart journal
ISSN: 1349-3299
Titre abrégé: Int Heart J
Pays: Japan
ID NLM: 101244240
Informations de publication
Date de publication:
31 Mar 2023
31 Mar 2023
Historique:
medline:
4
4
2023
pubmed:
18
3
2023
entrez:
17
3
2023
Statut:
ppublish
Résumé
Immunosuppressive therapy with prednisolone (PSL) is the first-line treatment for cardiac sarcoidosis (CS), and
Substances chimiques
Prednisolone
9PHQ9Y1OLM
Fluorodeoxyglucose F18
0Z5B2CJX4D
Radiopharmaceuticals
0
Types de publication
Observational Study
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
196-202Commentaires et corrections
Type : CommentIn